ConductScience.org, home

Paper25901682

Mutant MHC class II epitopes drive therapeutic immune responses to cancer.

Kreiter S and 14 others. Nature, 2015. Cited by 1,051 papers, by iCite.

Cite this record

ConductScience Library. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Papers, record 25901682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25901682

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mutant MHC class II epitopes drive therapeutic immune responses to cancer.
PubMed
Journal
Nature
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1,051
iCite
Relative citation ratio, by iCite
27.9
iCite
Revised in PubMed
2022-04-09
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kreiter SSebastian
2Vormehr MMathias
3van de Roemer NNiels
4Diken MMustafa
5Löwer MMartin
6Diekmann JJan
7Boegel SSebastian
8Schrörs BBarbara
9Vascotto FFulvia
10Castle JCJohn C
11Tadmor ADArbel D
12Schoenberger SPStephen P
13Huber CChristoph
14Türeci ÖÖzlem
15Sahin UUgur

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Epitopes, T-LymphocyteMajor topic
Histocompatibility Antigens Class IIMajor topic
ImmunotherapyMajor topic
Melanoma, ExperimentalMajor topic
MutationMajor topic
Algorithms
Animals
CD4-Positive T-Lymphocytes
Cancer Vaccines
Computer Simulation
Disease Models, Animal
Exome
Female
Humans
Mice
Precision Medicine
Sequence Analysis, DNA
Survival Analysis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AI107010NIAID NIH HHSUnited StatesR01AI107010PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Erratum in26040715Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer.https://conductscience.org/library/papers/26040715PubMed
Comment in26032267Cancer immunotherapy: exploiting neoepitopes.https://conductscience.org/library/papers/26032267PubMed

Download CSV of comments and corrections

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118026089Adaptive immunity maintains occult cancer in an equilibrium state.Nature2007https://conductscience.org/library/papers/18026089PubMed
225428504Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.Nature2014https://conductscience.org/library/papers/25428504PubMed
310334988Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen.Science1999https://conductscience.org/library/papers/10334988PubMed
416940422Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.Blood2006https://conductscience.org/library/papers/16940422PubMed
59058806Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.J Immunol1997https://conductscience.org/library/papers/9058806PubMed
67652577A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.Science1995https://conductscience.org/library/papers/7652577PubMed
725428505PD-1 blockade induces responses by inhibiting adaptive immune resistance.Nature2014https://conductscience.org/library/papers/25428505PubMed
825765070Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.Science2015https://conductscience.org/library/papers/25765070PubMed
924812403Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer.Science2014https://conductscience.org/library/papers/24812403PubMed
1020410931Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo.Gene Ther2010https://conductscience.org/library/papers/20410931PubMed
1125043048A vaccine targeting mutant IDH1 induces antitumour immunity.Nature2014https://conductscience.org/library/papers/25043048PubMed
1223690473Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression.J Immunol2013https://conductscience.org/library/papers/23690473PubMed
1321045153Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.Cancer Res2010https://conductscience.org/library/papers/21045153PubMed
1422397650Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.N Engl J Med2012https://conductscience.org/library/papers/22397650PubMed
1518097032Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals.J Immunol2008https://conductscience.org/library/papers/18097032PubMed
1623028300Confidence-based somatic mutation evaluation and prioritization.PLoS Comput Biol2012https://conductscience.org/library/papers/23028300PubMed
1724621249Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma.BMC Genomics2014https://conductscience.org/library/papers/24621249PubMed
1825531942High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.Nat Med2015https://conductscience.org/library/papers/25531942PubMed
1923644516Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells.Nat Med2013https://conductscience.org/library/papers/23644516PubMed
2024104749The regulatory landscape for actively personalized cancer immunotherapies.Nat Biotechnol2013https://conductscience.org/library/papers/24104749PubMed

See all 30 referencesDownload CSV of references

Cited by781

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,051 citations.

PMIDTitleJournalYearIn PapersSource
42871894A bottleneck-first evaluation of antigen delivery platforms for therapeutic cancer vaccines.Mater Today Bio2026https://conductscience.org/library/papers/42871894PubMed
42809703Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres.J Immunol2026https://conductscience.org/library/papers/42809703PubMed
42773266Metastasis enables immunogenicity through migrasome-mediated antigen release.Nat Immunol2026https://conductscience.org/library/papers/42773266PubMed
42722679Developing neoantigen cancer vaccines: where are we now?Nat Commun2026https://conductscience.org/library/papers/42722679PubMed
42696566Messenger RNA delivery of a dual CD25/CD122 affinity-tuned IL-2 variant prolongs exposure and potentiates antitumor T cell immunity.Sci Adv2026https://conductscience.org/library/papers/42696566PubMed
42694098Cancer Immunotherapy: Therapeutic Limitations and Next-Generation Precision Strategies.Immune Netw2026https://conductscience.org/library/papers/42694098PubMed
42621703Overcoming Drug Resistance by Paclitaxel Resistance in Triple-Negative Breast Cancer.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42621703PubMed
42595869Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy.Exp Mol Med2026https://conductscience.org/library/papers/42595869PubMed
42588678The Central Role of HLA Class II-Restricted Helper Neoantigen Vaccines in Cancer Immunotherapy.Cancers (Basel)2026https://conductscience.org/library/papers/42588678PubMed
42541646Past achievements and future perspectives of personalized vaccines and the role of dendritic cells.Immunol Res2026https://conductscience.org/library/papers/42541646PubMed
42509551Benchmarking sequence-based and AlphaFold-based methods for pMHC-II binding core prediction: distinct strengths and consensus approaches.BMC Med Genomics2026https://conductscience.org/library/papers/42509551PubMed
42509244The Dendritic Cell-based Vaccine PROTEXI leverages Antiviral CD4 T cell Memory to boost anti-tumor immune responses in mice.Nat Commun2026https://conductscience.org/library/papers/42509244PubMed
42506600Minicircle DNA Vaccines: Overcoming Delivery and Expression Barriers in Next-Generation Immunization.Vaccines (Basel)2026https://conductscience.org/library/papers/42506600PubMed
42481451Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42481451PubMed
42414668Chemically synthesized, non-capped and non-polyadenylated peptide-coding RNA efficiently induces antigen-specific CD8+ T cells.Nat Biomed Eng2026https://conductscience.org/library/papers/42414668PubMed
42344905Site-specific neoepitope induction by RNA editing reprograms tumor immunogenicity.Front Immunol2026https://conductscience.org/library/papers/42344905PubMed
42313973CD4+ T cells impair tumor growth through IL-3 and TNF-dependent vascular damage.Science2026https://conductscience.org/library/papers/42313973PubMed
42289978PMGen: from peptide-MHC structure prediction to peptide generation.Bioinformatics2026https://conductscience.org/library/papers/42289978PubMed
42256206CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses.Mol Ther Oncol2026https://conductscience.org/library/papers/42256206PubMed
42244090Human Organoids as a Novel Tool for Vaccine Study.Adv Healthc Mater2026https://conductscience.org/library/papers/42244090PubMed

See all 781 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
EMB133418PubTator's text mininghttps://conductscience.org/library/genes/133418NCBI Gene
HLA-DQA13117PubTator's text mininghttps://conductscience.org/library/genes/3117NCBI Gene
HLA-DQB13119PubTator's text mininghttps://conductscience.org/library/genes/3119NCBI Gene
HLA-DRB13123PubTator's text mininghttps://conductscience.org/library/genes/3123NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25901682

GET https://conductscience.org/api/papers/v1/25901682/references?page=2